Skip to content
Menu

Senseonics Initiates First-In-Human Study Of Freedom

Benzinga Newsdesk 3 weeks ago

BiotechGeneralNews

This page contains a summary, not the full article. Continue to benzinga.com to read the original report.

First clinical evaluation of investigational, transmitter-free one-year CGM marks an important milestone on Senseonics’ innovation roadmap, with potential launch in 2028Built on the proven sensing technology behind

First clinical evaluation of investigational, transmitter-free one-year CGM marks an important milestone on Senseonics’ innovation roadmap, with potential launch in 2028

Built on the proven sensing technology behind Eversense 365 and supported by encouraging preclinical data to reduce development risk

Read at benzinga.com